Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Relapsing Multiple Myeloma
NCT01470131Phase 3Terminated
- Sponsor
- AB Science
- Start
- May 2011
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of masitinib in multiple myeloma (MM), sponsored by AB Science. Started May 2011; status: terminated.
02
Drugs
masitinib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01470131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470131.